Financial statements Fdfpharma
Balance sheet data of FDFPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 185 709,15 | 190 613,68 | 228 693,82 | 269 224,50 | 215 530,23 | 247 184,78 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 185 709,15 | 190 613,68 | 228 693,82 | 269 224,50 | 215 530,23 | 247 184,78 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 185 709,15 | 190 613,68 | 228 693,82 | 269 224,50 | 215 530,23 | 247 184,78 |
| A. Equity | 172 883,65 | 178 025,18 | 209 534,32 | 249 529,65 | 194 372,73 | 226 761,61 |
| B. Liabilities and provisions for liabilities | 12 825,50 | 12 588,50 | 19 159,50 | 19 694,85 | 21 157,50 | 20 423,17 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 12 825,50 | 12 588,50 | 19 159,50 | 19 694,85 | 21 157,50 | 20 423,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.